Janus Henderson Group’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.16M Sell
72,736
-6,245
-8% -$614K ﹤0.01% 801
2025
Q1
$7.33M Sell
78,981
-13,715
-15% -$1.27M ﹤0.01% 773
2024
Q4
$8.42M Hold
92,696
﹤0.01% 763
2024
Q3
$8.95M Hold
92,696
﹤0.01% 709
2024
Q2
$8.51M Sell
92,696
-193,072
-68% -$17.7M ﹤0.01% 701
2024
Q1
$26.3M Sell
285,768
-83,985
-23% -$7.74M 0.01% 516
2023
Q4
$35.1M Sell
369,753
-103,750
-22% -$9.86M 0.02% 442
2023
Q3
$44.2M Sell
473,503
-23,933
-5% -$2.24M 0.03% 386
2023
Q2
$45.5M Buy
497,436
+482,999
+3,346% +$44.2M 0.03% 402
2023
Q1
$1.06M Sell
14,437
-6,840
-32% -$503K ﹤0.01% 1595
2022
Q4
$1.78M Sell
21,277
-23,917
-53% -$2M ﹤0.01% 1134
2022
Q3
$4.37M Buy
45,194
+24,769
+121% +$2.4M ﹤0.01% 1030
2022
Q2
$2.15M Sell
20,425
-923
-4% -$97K ﹤0.01% 1022
2022
Q1
$3.68M Sell
21,348
-6,227
-23% -$1.07M ﹤0.01% 1077
2021
Q4
$4.46M Buy
27,575
+835
+3% +$135K ﹤0.01% 1092
2021
Q3
$3.99M Buy
26,740
+2,417
+10% +$360K ﹤0.01% 1108
2021
Q2
$5.96M Buy
24,323
+404
+2% +$98.9K ﹤0.01% 1027
2021
Q1
$6.33M Buy
23,919
+2,152
+10% +$570K ﹤0.01% 974
2020
Q4
$6.39M Buy
21,767
+2,993
+16% +$878K ﹤0.01% 922
2020
Q3
$4.44M Buy
18,774
+4,571
+32% +$1.08M ﹤0.01% 930
2020
Q2
$2.82M Buy
14,203
+7,419
+109% +$1.47M ﹤0.01% 986
2020
Q1
$1.25M Sell
6,784
-349
-5% -$64K ﹤0.01% 1073
2019
Q4
$1.19M Sell
7,133
-1,434
-17% -$239K ﹤0.01% 1214
2019
Q3
$1.12M Buy
8,567
+3,360
+65% +$440K ﹤0.01% 1211
2019
Q2
$632K Buy
5,207
+803
+18% +$97.5K ﹤0.01% 1241
2019
Q1
$543K Buy
4,404
+54
+1% +$6.66K ﹤0.01% 1235
2018
Q4
$509K Sell
4,350
-395
-8% -$46.2K ﹤0.01% 1227
2018
Q3
$593K Buy
4,745
+471
+11% +$58.9K ﹤0.01% 1306
2018
Q2
$365K Sell
4,274
-677
-14% -$57.8K ﹤0.01% 1316
2018
Q1
$299K Buy
+4,951
New +$299K ﹤0.01% 1310
2017
Q4
Sell
-4,144
Closed -$232K 1304
2017
Q3
$232K Sell
4,144
-289
-7% -$16.2K ﹤0.01% 1267
2017
Q2
$278K Buy
+4,433
New +$278K ﹤0.01% 1277